Showing 2671-2680 of 4166 results for "".
- GenSight Biologics Announces Publication of Results of Lumevoq REFLECT Pivotal Clinical Trialhttps://modernod.com/news/gensight-biologics-announces-publication-of-results-of-lumevoq-reflect-pivotal-clinical-trial/2481250/GenSight Biologics announced that the neurology journal BRAIN has published efficacy and safety findings at 1.5-year post-treatment in ND4-LHON patients treated with lenadogene nolparvovec (Lumevoq) from the REFLECT pivotal clinical trial. The REF
- Oyster Point Pharma to Present New Clinical Data at ASCRS 2022https://modernod.com/news/oyster-point-pharma-to-present-new-clinical-data-at-ascrs-2022/2480775/Oyster Point Pharma announced the presentation of data analyses at the American Society of Cataract and Refractive Surgery (ASCRS), being held on April 22-26. The company-sponsored clinical trials that will be presented highlight the recently approved Tyrvaya (varenicline solution)
- MeiraGTx Receives Clinical Development Milestone Payment from Janssenhttps://modernod.com/news/meiragtx-receives-clinical-development-milestone-payment-from-janssen/2480599/MeiraGTx Holdings announced that it has received a $30 million payment from Johnson & Johnson's Janssen Pharmaceuticals for a clinical milestone in the phase 3 Lumeos trial of botaretigene sparoparvovec (AAV-RPGR), an investigational gene therapy for the treatment of X-linked retinit
- Oxurion to Present Clinical and Preclinical Data at Upcoming Euretina 2021 Virtual Congresshttps://modernod.com/news/oxurion-to-present-clinical-and-preclinical-data-at-upcoming-euretina-2021-virtual-congress/2479493/Oxurion NV will be presenting preclinical and clinical data from its ongoing development programs, THR-149 and THR-687, as novel treatments for diabetic macular edema (DME) at the Euretina 2021 virtual congress. The upcoming annual meeting of the European Society of Retina Specialists is taking p
- Oxurion NV to Focus Resources on Clinical Assets THR-687 and THR-149https://modernod.com/news/oxurion-nv-to-focus-resources-on-clinical-assets-thr-687-and-thr-149/2479325/Oxurion announced a restructuring plan aimed at better aligning resources towards executing its clinical development strategy, including advancing its two novel programs, THR-687 and THR-149, according to a company news release. Following a detailed review of its operations and gr
- Lighthouse Guild Announces the Naming of The Dorothy Strelsin Behavioral Health Clinichttps://modernod.com/news/lighthouse-guild-announces-the-naming-of-the-dorothy-strelsin-behavioral-health-clinic/2479278/In recognition of a long-time supporter of Lighthouse Guild, the organization has announced the naming of The Dorothy Strelsin Behavioral Health Clinic. Lighthouse Guild is very grateful for the steadfast support of Dorothy Strelsin, who in her lifetime made numerous initiatives possible, includi
- Visus Therapeutics Initiates Phase 2 Clinical Trial of Brimochol for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-initiates-phase-2-clinical-trial-of-brimochol-for-the-treatment-of-presbyopia/2479013/Visus Therapeutics announced the commencement of its phase 2 clinical trial of Brimochol topical ophthalmic solution under investigation for the treatment of presbyopia. Brimochol is a proprietary pupil-modulating eye drop that combines two well-studied, FDA-approved pharmaceuticals: carb
- ScienceBased Health Announces Expansion of its Optometry Clinical Advisory Panelhttps://modernod.com/news/sciencebased-health-announces-expansion-of-its-optometry-clinical-advisory-panel/2478537/ScienceBased Health (SBH), a provider of nutraceuticals for eye health, announced the addition of Tracy Doll, OD, FAAO; Scott Hauswirth, OD, FAAO; and Justin Schweitzer, OD, FAAO, to its Clinical Advisory Panel. “We’re honored to welcome these distinguished practitioners to our Clini
- Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual Meetinghttps://modernod.com/news/eyenovia-to-present-clinical-study-updates-at-the-american-academy-of-optometry-annual-meeting/2478390/Eyenovia announced that Drs. Siddarth Rathi and April Jasper will present the latest analyses and updates from the company’s clinical studies at the American Academy of Optometry Academy 2020 At Home Conference. On Wednesday, October 7, April Jasper, OD, medical monitor for the company’s C
- Neuroptika Completes Enrollment In Phase 2 Clinical Trial For Dry Eye Diseasehttps://modernod.com/news/neuroptika-completes-enrollment-in-phase-2-clinical-trial-for-dry-eye-disease/2478192/Neuroptika announced completion of enrollment in a phase 2 clinical controlled, double-masked trial of NRO-1 for the treatment of patients with dry eye disease. NRO-1 is a novel therapeutic with the potential to regenerate corneal nerves in ophthalmic diseases. “We are pleased to com